iRGD-CDD
General Information
DCTPep ID DCTPep05370
Peptide Name iRGD-CDD
Sequence CRGDKGPDC
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Membrane-targeted Cell-penetrating peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Penetrating Human embryonic kidney (HEK) 293T, prostate cancer PPC1,mouse breast cancer 4T1, Human tumor cell line M21, Human breast cancer cell line MCF-10CA1a
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C35H59N13O14S2
Absent amino acids AEFHILMNQSTVWY
Theoretical pI 5.95
Acidic residues 2
Basic residues 2
Polar residues 4
Molecular weight (Average) 950.05
Molecular weight (Monoisotopic) 949.37
Common amino acids CDG
Net charge 0
Instability index (II) -27.79
Aliphatic index 0.00
Grand average of hydropathicity (GRAVY) -1.422
Half Life
1.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 125
Abs 0.1% (=1 g/l) 0.132, assuming all pairs of Cys residues form cystines
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23248118
Title Not available
Doi Not available
Year Not available
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
Cppsite ID 2081